Technology News: May 2011
Health Application in Demand Straub Clinic and Hospital and Kauai Medical Clinic becomes the first healthcare facility centre to allow […]
Tags: biotechnology, Broadband Technology, chronic diseases, drug delivery, genetic engineering, health information technology, healthcare, healthcare facilities, healthcare facility centre, healthcare information, hepatitis, information technology, laser, lasers, low energy electrons, Melbourne, Merck, Merck & Co, saved travel time, serious infection, specialist, Sun Pharma, Sun Pharmaceutical Industries, surgery, telemedicine, United Kingdom, United States, USD, video conferencing
Glenmark tops the charts in US
US approve the sale of low cost medicines by Glenmark Pharmaceuticals this financial year by winning the bids against Sun Pharma, Ranbaxy Laboratories and Dr Reddy.
Wockhardt in Debt
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
Sun Pharma receives USFDA nod for generic Clarinex, Tiazac
The Mumbai-based firm has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) to market a generic version of Schering Plough’s Clarinex tablets, Sun Pharma said in a statement.
Sun gets USFDA nod for generic heart disease drug
Drug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.
Wockhardt jumps on US FDA nod for generic drug
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
“Clinical Research is a recession-proof industry” : Vijay Moza, CREMA – Clinical Research Education and Management Academy
CREMA – Clinical Research Education and Management Academy, is a premier training and research institute in Clinical and Biomedical studies. Launched in 2007 in Mumbai, it runs three campuses at Bengaluru, New Delhi and Hyderabad and plans to set up three more centers by the end of 2009. Last year CREMA started a full-time Advanced Post Graduate Ddiploma in Clinical Research.
Wockhardt hiving off R&D business
Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.
Blogs new window to the world for Pharma industry
Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.
